Our Approach To Chronic Lymphocytic Leukemia in Adults

What Sets Us Apart

At NYU Langone’s Perlmutter Cancer Center, oncologists, hematologists, and pathologists work together to diagnose and manage chronic lymphocytic leukemia (CLL). This cancer of the blood and bone marrow typically progresses slowly and requires ongoing monitoring and care.

Our physicians can determine whether people with chronic lymphocytic leukemia can safely delay treatment or should begin customized therapies to help manage the disease. Integrative health specialists, social workers, and psychologists are also available to provide support to people living with this chronic illness.


At NYU Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.Find a Clinical Trial

Treatment at NYU Langone

For some people with chronic lymphocytic leukemia, NYU Langone doctors may recommend a period of watchful waiting, during which doctors monitor but do not treat the condition. Other people may begin chemotherapy or take newly approved targeted therapies to best manage this condition.

More Resources

Meet Our Doctors

NYU Langone specialists provide care and support throughout your entire healthcare journey.

Browse Doctors